Evidence map›Paper›PMID 35445969›Full record

ReviewTranslational stroke research2023

Optical Coherence Tomography in Cerebrovascular Disease: Open up New Horizons.

Ran Xu, Qing Zhao, Tao Wang, Yutong Yang, Jichang Luo, Xiao Zhang, Yao Feng, Yan Ma, Adam A Dmytriw, Ge Yang and 3 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Translational stroke research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Ran Xu *Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China.
Qing Zhao *M.D. Program, Peking Union Medical College, No. 9 Dongdansantiao Street, Beijing, 100730, China.
Tao WangDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China.
Yutong YangFaculty of Medicine, National Heart & Lung Institute, Imperial College London, G210 Guy Scadding Building, London, SW3 6LY, UK.
Jichang LuoDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China.
Xiao ZhangDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China.
Yao FengDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China.
Yan MaDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China.
Adam A DmytriwNeuroendovascular Program, Massachusetts General Hospital, Boston, MA, 02114, USA.
Ge YangNational Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Science, Beijing, 100190, China.
Shengpan ChenDepartment of Neurosurgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, No. 106, Zhongshan 2nd Road, Guangzhou, 510080, Guangdong Province, China.
Bin YangDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China. yangbin_81@163.com.
Liqun JiaoDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China. liqunjiao@sina.cn.ORCID http://orcid.org/0000-0003-4982-6295
Capital Medical University · CNBrigham and Women's Hospital · USChinese Academy of Medical Sciences & Peking Union Medical College · CNGuangdong Academy of Medical Sciences · CNImperial College London · GBInstitute of Automation · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optical coherence tomography (OCT), based on the backscattering or reflection of near-infrared light, enables an ultra-high resolution of up to 10 μm. The successful application of OCT in coronary artery diseases has sparked increasing interest in its implementation in cerebrovascular diseases. OCT has shown promising potential in the atherosclerotic plaque structure characterization, plaque rupture risk stratification, pre-stenting and post-stenting evaluation, and long-term follow-up in extracranial and intracranial atherosclerotic stenosis (ICAS). In hemorrhagic cerebrovascular diseases, OCT plays an important role in the structure evaluation, rupture risk stratification, and healing and occlusion evaluation following initial treatment in intracranial aneurysms (IAs). In this study, we summarized the applications of OCT in the diagnosis, treatment, and follow-up of cerebrovascular diseases, especially in ICAS and IAs. The current limitations and future directions of OCT in the endovascular treatment of cerebrovascular diseases were also discussed.

Indexed as

Coronary Artery DiseaseIntracranial AneurysmPlaque, AtheroscleroticVascular DiseasesHumansStentsTomography, Optical CoherenceICASIntracranial AneurysmOCTPlaque structure

Identifiers

PMID35445969
OpenAlexW4224283343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.